Please use this identifier to cite or link to this item:
Title: Drug-resistant Streptococcus pneumoniae
Author: Pallarés Giner, Roman
Liñares Louzao, Josefina
Gudiol i Munté, Francesc
Keywords: Resistència als medicaments
Drug resistance
Streptococcus pneumonia
Issue Date: 4-Jan-1996
Publisher: Massachusetts Medical Society
Abstract: To the Editor: since the first description of infection caused by β-lactam-resistant Streptococcus pneumoniae, the optimal empirical antibiotic therapy for patients with suspected meningitis caused by this microorganism has remained unknown. Hofmann et al. (Aug. 24 issue)1 reported a 25 percent prevalence of penicillin-resistant S. pneumoniae isolates and a 9 percent prevalence of cephalosporin-resistant isolates among 431 patients with invasive pneumococcal infections in Atlanta. The authors recommended adding vancomycin to the initial therapeutic regimen of patients with suspected pneumococcal meningitis.
Note: Reproducció del document publicat a:
It is part of: New England Journal of Medicine, 1996, vol. 334, p. 53-55
Related resource:
ISSN: 0028-4793
Appears in Collections:Articles publicats en revistes (Ciències Clíniques)

Files in This Item:
File Description SizeFormat 
124264.pdf104.92 kBAdobe PDFView/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.